mRNA |
GW 441756 |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.6 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.7 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.7 |